Veru reaches agreement with fda on confirmatory phase 3 clinical trial for sabizabulin treatment of hospitalized covid-19 adult patients at high risk for ards

Reached agreement with fda on confirmatory phase 3 clinical trial design in 408 subjects with primary endpoint of all-cause mortality at day 60
VERU Ratings Summary
VERU Quant Ranking